The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer

The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer

Introduction and Objectives. The neutrophil-to-lymphocyte ratio (NLR) has been suggested as a simple marker of the systemic inflammatory response in critical care patients. The NLR can be easily calculated from routine complete blood counts in the peripheral blood. This parameter has been reported t...

Full description

Bibliographic Details
Main Authors:	Tomoyuki Tatenuma, Takashi Kawahara, Narihiko Hayashi, Hisashi Hasumi, Kazuhide Makiyama, Noboru Nakaigawa, Takeshi Kishida, Yasuhide Miyoshi, Masahiro Yao, Hiroji Uemura
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2019/2535270

Similar Items

Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy
by: Koichi Uemura, et al.
Published: (2017-01-01)

Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel.
by: Takashi Kawahara, et al.
Published: (2012-01-01)

The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer
by: Genta Iwamoto, et al.
Published: (2021-07-01)

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide
by: Yohei Kumano, et al.
Published: (2019-01-01)

A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
by: Rumiko Sugimura, et al.
Published: (2019-09-01)

The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis
by: Taku Mochizuki, et al.
Published: (2017-06-01)

Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
by: Takashi Kawahara, et al.
Published: (2019-07-01)

Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
by: Shinji Ohtake, et al.
Published: (2016-01-01)

Renal Cell Carcinoma in a Horseshoe Kidney Treated with Laparoscopic Partial Nephrectomy
by: Shinji Ohtake, et al.
Published: (2018-01-01)

Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
by: Koichi Uemura, et al.
Published: (2018-05-01)

Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab
by: Tadashi Tabei, et al.
Published: (2019-04-01)

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
by: Takashi Kawahara, et al.
Published: (2018-11-01)

Clinical outcome of surgical management for symptomatic metastatic spinal cord compression from prostate cancer
by: Yasuhide Miyoshi, et al.
Published: (2020-09-01)

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
by: Takashi Kawahara, et al.
Published: (2019-08-01)

The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday
by: Takashi Kawahara, et al.
Published: (2019-07-01)

A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
by: Takashi Kawahara, et al.
Published: (2020-09-01)

Ureter metastatic castration-resistant prostate cancer: a case report
by: Sohgo Tsutsumi, et al.
Published: (2017-09-01)

Gallbladder Metastasis from Renal Cell Carcinoma
by: Takashi Kawahara, et al.
Published: (2010-01-01)

Neuroendocrine Carcinoma of the Bladder
by: Takashi Kawahara, et al.
Published: (2010-03-01)

Fluorescent Light-Guided Cystoscopy with 5-ALA Aids in Accurate Surgical Margin Detection for TURBO: A Case Report
by: Daiji Takamoto, et al.
Published: (2018-03-01)

Primary Synovial Sarcoma of the Kidney
by: Takashi Kawahara, et al.
Published: (2009-10-01)

Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis
by: Ryota Morinaga, et al.
Published: (2019-08-01)

Inserting a Metallic Ureteral Stent Using an Antegrade Approach Freed a Patient from Nephrostomy Created due to Hydronephrosis Caused by Bladder Cancer
by: Takashi Kawahara, et al.
Published: (2019-07-01)

Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy
by: Takashi Kawahara, et al.
Published: (2019-07-01)

Sarcomatoid Variant of Bladder Carcinoma: A Case Report
by: Koichi Uemura, et al.
Published: (2018-09-01)

Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report
by: Sohgo Tsutsumi, et al.
Published: (2018-02-01)

A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
by: Ryo Kasahara, et al.
Published: (2017-01-01)

Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
by: Filippo Francini, et al.
Published: (2011-01-01)

Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure
by: Mari Ohtaka, et al.
Published: (2018-05-01)

Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
by: Maelle Le Thiec, et al.
Published: (2020-06-01)

Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
by: Yue-Feng Wen, et al.
Published: (2017-01-01)

The Influence of Pretherapeutic and Preoperative Sarcopenia on Short-Term Outcome after Esophagectomy
by: Johanna Grün, et al.
Published: (2020-11-01)

Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
by: Hui-Li Wong, et al.
Published: (2015-06-01)

Clinical outcomes in castration resistant prostate cancer patients treated with docetaxel
by: Shian-Shiang Wang, et al.
Published: (2016-06-01)

A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy
by: Yoko Saitoh-Maeda, et al.
Published: (2017-09-01)

A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.
by: Go Noguchi, et al.
Published: (2020-01-01)

Preparation for pyeloplasty for ureteropelvic junction obstruction using a patient-specific laparoscopic simulator: a case report
by: Yamanaka Hiroyuki, et al.
Published: (2012-10-01)

Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel risk stratification model in castration-resistant prostate cancer patients treated with docetaxel chemotherapy
by: Yoshihiro Nakagami, et al.
Published: (2015-06-01)

Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer.
by: Christine Staudigl, et al.
Published: (2015-01-01)

Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer
by: Manuel Caitano Maia, et al.
Published: (2017-03-01)